JP2018507260A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507260A5
JP2018507260A5 JP2017564757A JP2017564757A JP2018507260A5 JP 2018507260 A5 JP2018507260 A5 JP 2018507260A5 JP 2017564757 A JP2017564757 A JP 2017564757A JP 2017564757 A JP2017564757 A JP 2017564757A JP 2018507260 A5 JP2018507260 A5 JP 2018507260A5
Authority
JP
Japan
Prior art keywords
configuration
patient
iron
configurations
ferric citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017564757A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507260A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/020575 external-priority patent/WO2016141124A1/en
Publication of JP2018507260A publication Critical patent/JP2018507260A/ja
Publication of JP2018507260A5 publication Critical patent/JP2018507260A5/ja
Pending legal-status Critical Current

Links

JP2017564757A 2015-03-04 2016-03-03 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用 Pending JP2018507260A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562127963P 2015-03-04 2015-03-04
US62/127,963 2015-03-04
PCT/US2016/020575 WO2016141124A1 (en) 2015-03-04 2016-03-03 Use of ferric citrate in the treatment of iron-deficiency anemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021010151A Division JP2021091686A (ja) 2015-03-04 2021-01-26 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用

Publications (2)

Publication Number Publication Date
JP2018507260A JP2018507260A (ja) 2018-03-15
JP2018507260A5 true JP2018507260A5 (enExample) 2019-04-11

Family

ID=56848619

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017564757A Pending JP2018507260A (ja) 2015-03-04 2016-03-03 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用
JP2021010151A Pending JP2021091686A (ja) 2015-03-04 2021-01-26 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021010151A Pending JP2021091686A (ja) 2015-03-04 2021-01-26 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用

Country Status (15)

Country Link
US (2) US20180071243A1 (enExample)
EP (1) EP3265077A4 (enExample)
JP (2) JP2018507260A (enExample)
KR (1) KR20170123664A (enExample)
CN (1) CN107530310A (enExample)
AU (1) AU2016226250B2 (enExample)
BR (1) BR112017018963A2 (enExample)
CA (1) CA2978073A1 (enExample)
EA (1) EA201791960A1 (enExample)
HK (2) HK1246649A1 (enExample)
IL (1) IL254125A0 (enExample)
MX (1) MX2017011169A (enExample)
SG (1) SG11201707120PA (enExample)
TW (2) TW202302083A (enExample)
WO (1) WO2016141124A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573807A (zh) 2009-07-21 2012-07-11 凯克斯生物制药公司 柠檬酸铁剂型
JP7387435B2 (ja) * 2017-09-19 2023-11-28 日本たばこ産業株式会社 過多月経患者及び/又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び/又は治療におけるクエン酸第二鉄の使用
FR3075601A1 (fr) * 2017-12-21 2019-06-28 Clarisse Le Court Complements alimentaires et leur utilisation sur les menstruations
WO2020247935A1 (en) * 2019-06-07 2020-12-10 Arizona Board Of Regents On Behalf Of Arizona State University Body fluid iron level panel analyzer
WO2022251563A1 (en) 2021-05-27 2022-12-01 Keryx Biopharmaceuticals, Inc. Pediatric formulations of ferric citrate
WO2023047424A1 (en) * 2022-04-29 2023-03-30 West Bengal Chemical Industries Limited Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093423B2 (en) * 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
WO2005067970A1 (ja) * 2004-01-14 2005-07-28 Gekkeikan Sake Co., Ltd. 鉄補給剤及びその利用
JP4931352B2 (ja) * 2004-01-14 2012-05-16 月桂冠株式会社 鉄補給剤及びその利用
JP5667343B2 (ja) * 2005-08-18 2015-02-12 パニオン アンド ビーエフ バイオテック インコーポレーテッド 医薬グレードの第二鉄有機化合物、その使用およびその製造方法
US20120288531A1 (en) * 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
EA201590062A1 (ru) * 2012-06-21 2016-02-29 Керикс Байофармасьютикалз, Инк. Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью

Similar Documents

Publication Publication Date Title
JP2018507260A5 (enExample)
Garrido-Martín et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial
Albacker et al. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients
Higo et al. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy
JP2020100638A (ja) 慢性腎臓病患者の治療におけるクエン酸第二鉄の使用
JP2023145717A (ja) 貧血治療のための組成物及び方法
JP2015164964A5 (enExample)
JP6828100B2 (ja) 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
Hu et al. Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges
JP2018510178A (ja) 貧血治療のための組成物及び方法
JP7578243B2 (ja) アルカリ性化剤による血液浄化
JP2013515719A (ja) 循環器疾患の処置に有用な組み合わせ組成物
AU2016226250B2 (en) Use of ferric citrate in the treatment of iron-deficiency anemia
Xie et al. Obstructive sleep apnea hypopnea syndrome as a reason for active management of pulmonary embolism
WO2016085986A1 (en) High density lipoprptein nanoparticles for inflammation
Spiridonova et al. Etiology and pathogenesis of burn anemia. The role of the blood transfusion in the treatment of patients with burns
Tortora et al. Management of gastrointestinal bleeding in rendu-osler disease
JP2010526068A5 (enExample)
Meeran et al. The systemic inflammatory response syndrome
JP7505160B2 (ja) ヒドロキシ尿素を含む炎症反応を阻害するための医薬組成物
Fujihara et al. Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases
JP2012031141A (ja) 骨髄異形性症候群を治療するための組成物および方法
TW201813639A (zh) 氯硝柳胺及其衍生物的用途
Qiu et al. Pharmacokinetics of pilsicainide hydrochloride for injection in healthy Chinese volunteers: a randomized, parallel-group, open-label, single-dose study
JP6443935B2 (ja) 動脈硬化の治療または予防のためのアスピリンおよび葉酸の併用